115 related articles for article (PubMed ID: 33090479)
1. Effectiveness of osteoporosis medication on site-specific fracture-risk attenuation among adults with epilepsy.
Whitney DG
Epilepsia; 2020 Nov; 61(11):2583-2592. PubMed ID: 33090479
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Osteoporosis Medication on Risk Attenuation of Non-Trauma Fracture Among Adults with Cerebral Palsy: A Propensity Score-Matched Observational Study.
Whitney DG; Hurvitz EA; Caird MS
Clin Epidemiol; 2021; 13():91-102. PubMed ID: 33603490
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis medication is associated with mortality risk reduction among adults with epilepsy: An observational study.
Whitney DG
Bone; 2021 Sep; 150():116003. PubMed ID: 33984552
[TBL] [Abstract][Full Text] [Related]
4. The mortality burden attributable to nontrauma fracture for privately insured adults with epilepsy.
Whitney DG; Bell S; McNamara NA; Hurvitz EA
Epilepsia; 2020 Apr; 61(4):714-724. PubMed ID: 32108937
[TBL] [Abstract][Full Text] [Related]
5. The effect of age when initiating anti-seizure medication therapy on fragility fracture risk for children with epilepsy.
Whitney DG; Kalia V; Rajapakse CS; Fedak Romanowski EM; Caird MS; Hurvitz EA; Jepsen KJ
Bone; 2021 Aug; 149():115996. PubMed ID: 33962082
[TBL] [Abstract][Full Text] [Related]
6. Effect of levetiracetam and oxcarbazepine on 4-year fragility fracture risk among prepubertal and pubertal children with epilepsy.
Whitney DG; Caird MS; Hurvitz EA; Rajapakse CS; Fedak Romanowski EM
Epilepsia; 2021 Sep; 62(9):2180-2189. PubMed ID: 34250606
[TBL] [Abstract][Full Text] [Related]
7. Risk for respiratory and cardiovascular disease and mortality after non-trauma fracture and the mediating effects of respiratory and cardiovascular disease on mortality risk among adults with epilepsy.
Whitney DG; Kannikeswaran S; Whibley D
Epilepsy Res; 2020 Oct; 166():106411. PubMed ID: 32679488
[TBL] [Abstract][Full Text] [Related]
8. The cardiovascular disease burden of non-traumatic fractures for adults with and without cerebral palsy.
Whitney DG; Bell S; Etter JP; Prisby RD
Bone; 2020 Jul; 136():115376. PubMed ID: 32335375
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced peripheral neuropathy increases nontraumatic fracture risk in breast cancer survivors.
McNeish BL; Richardson JK; Bell SG; Whitney DG
JBMR Plus; 2021 Aug; 5(8):e10519. PubMed ID: 34368609
[TBL] [Abstract][Full Text] [Related]
10. The mortality burden of non-trauma fracture for adults with cerebral palsy.
Whitney DG; Bell S; Hurvitz EA; Peterson MD; Caird MS; Jepsen KJ
Bone Rep; 2020 Dec; 13():100725. PubMed ID: 33088868
[TBL] [Abstract][Full Text] [Related]
11. Nontrauma fracture increases risk for respiratory disease among adults with cerebral palsy.
Whitney DG
J Orthop Res; 2020 Dec; 38(12):2551-2558. PubMed ID: 32233002
[TBL] [Abstract][Full Text] [Related]
12. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells GA; Cranney A; Peterson J; Boucher M; Shea B; Robinson V; Coyle D; Tugwell P
Cochrane Database Syst Rev; 2008 Jan; (1):CD001155. PubMed ID: 18253985
[TBL] [Abstract][Full Text] [Related]
13. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
[TBL] [Abstract][Full Text] [Related]
14. The near absence of osteoporosis treatment in older men with fractures.
Feldstein AC; Nichols G; Orwoll E; Elmer PJ; Smith DH; Herson M; Aickin M
Osteoporos Int; 2005 Aug; 16(8):953-62. PubMed ID: 15928798
[TBL] [Abstract][Full Text] [Related]
15. Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults.
Zullo AR; Zhang T; Lee Y; McConeghy KW; Daiello LA; Kiel DP; Mor V; Berry SD
J Am Geriatr Soc; 2019 Apr; 67(4):768-776. PubMed ID: 30575958
[TBL] [Abstract][Full Text] [Related]
16. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries.
Yusuf AA; Matlon TJ; Grauer A; Barron R; Chandler D; Peng Y
Arch Osteoporos; 2016 Dec; 11(1):31. PubMed ID: 27696099
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate use after clinical fracture and risk of new fracture.
Bergman J; Nordström A; Nordström P
Osteoporos Int; 2018 Apr; 29(4):937-945. PubMed ID: 29397408
[TBL] [Abstract][Full Text] [Related]
18. The respiratory disease burden of non-traumatic fractures for adults with cerebral palsy.
Etter JP; Kannikeswaran S; Hurvitz EA; Peterson MD; Caird MS; Jepsen KJ; Whitney DG
Bone Rep; 2020 Dec; 13():100730. PubMed ID: 33195765
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic threshold for osteoporosis impedes fracture prevention in women at high risk for fracture: A registry-based cohort study.
Leslie WD; Seeman E; Morin SN; Lix LM; Majumdar SR
Bone; 2018 Sep; 114():298-303. PubMed ID: 30008396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
